In vitro models suggest low EMILIN-1 levels correlate with aggressive phenotypes [64], while bioinformatics analyses paradoxically link high EMILIN-1 expression to poor prognosis in low-grade gliomas [65]. The gene discussed is EMILIN1; the disease is central nervous system cancer.